Patient Care
About
09.21.23
Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma
by Alex Kadhim
09.21.23
Dual-split CD38/CD138 CAR targeting for multiple myeloma
by ASTCT Science Highlights
09.19.23
FLT3-specific UniCAR T-cell therapy against AML
by ASTCT Science Highlights
09.18.23
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma
by Alex Kadhim
09.14.23
Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure
by Alex Kadhim
08.30.23
Visualizing Breakthroughs: ASTCT 2022 CAR T Webinar Infographics
by ASTCT
08.24.23
Off-the-shelf FLT3 CAR against AML
by ASTCT Science Highlights
08.22.23
Long-acting IL-7 boosts BCMA CAR-iNKT effects against MM
by ASTCT Science Highlights
08.17.23
CAR T cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure
by Alex Kadhim
Load next 9 article(s) (100 left)
Loading...
THANK YOU TO OUR SPONSORS
Search